[1]. Franco FM, Bussmann RW. Rising to the occasion: outlining Ethnobiologists’ response to the coronavirus (COVID-19) pandemic. Ethnobotany Research and Applications. 2020 May 29;20:1-4.
[2]. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Military Medical Research. 2020 Dec;7(1):1-0.
[3]. Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. Journal of medical virology. 2020 Apr;92(4):418-23.
[4]. Chowell G, Abdirizak F, Lee S, Lee J, Jung E, Nishiura H, Viboud C. Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study. BMC medicine. 2015 Dec;13(1):1-2.
[5]. Chowell G, Abdirizak F, Lee S, Lee J, Jung E, Nishiura H, Viboud C. Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study. BMC medicine. 2015 Dec;13(1):1-2.
[6]. Emanuel EJ, Persad G, Upshur R, Thome B, Parker M, Glickman A, Zhang C, Boyle C, Smith M, Phillips JP. Fair allocation of scarce medical resources in the time of Covid-19.
[7]. Wu, Z., & McGoogan, J. M. (2020). Asymptomatic and pre-symptomatic COVID-19 in China..
[8]. MUKUNDAN, M. K. (2020). Towards a Tangible Defense Against the Covid 19 Infection.
[9]. Ji W, Bishnu G, Cai Z, Shen X. Analysis clinical features of COVID-19 infection in secondary epidemic area and report potential biomarkers in evaluation. MedRxiv. 2020 Jan.
[10]. Traggiai E, Becker S, Subbarao K, Kolesnikova L, Uematsu Y, Gismondo MR, Murphy BR, Rappuoli R, Lanzavecchia A. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nature medicine. 2004 Aug;10(8):871-5.
[11]. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, evaluation and treatment coronavirus (COVID-19). Statpearls [internet]. 2020 Mar 8.
[12]. Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International journal of surgery. 2020 Apr 1;76:71-6.
[13]. Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International journal of surgery. 2020 Apr 1;76:71-6.
[14]. Elizalde-González JJ. SARS-CoV-2 and COVID-19. A pandemic review.
[15]. Read JM, Bridgen JR, Cummings DA, Ho A, Jewell CP. Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions. MedRxiv. 2020 Jan.
[16] . Ciardullo S, Zerbini F, Perra S, Muraca E, Cannistraci R, Lauriola M, Grosso P, Lattuada G, Ippoliti G, Mortara A, Manzoni G. Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy. Journal of Endocrinological Investigation. 2020 Aug 10:1-8.
[17]. Li H, Tian S, Chen T, Cui Z, Shi N, Zhong X, Qiu K, Zhang J, Zeng T, Chen L, Zheng J. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID‐19. Diabetes, Obesity and Metabolism. 2020 Oct;22(10):1897-906.
[18]. Al Hayek AA, Robert AA, Alotaibi ZK, Al Dawish M. Clinical characteristics of hospitalized and home isolated COVID-19 patients with type 1 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020 Nov 1;14(6):1841-5.
[19]. Wang VX, Xing BB. Talk about the coronavirus pandemic: Initial evidence from corporate disclosures. Available at SSRN 3585951. 2020 Apr 26.
[20]. Price, R. (2018). Iraqi state capabilities.
[21].Aljawareen, A. F. (2019). Iraqi Economy Post ISIS: Challenges and Opportunities. Manag Econ Res J, 5(2019), 9565..